Clinical Trial Update: Myocardial Perfusion Imaging Galmydar Rest/Stress [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 trial evaluating the myocardial perfusion imaging agent Galmydar for rest and stress imaging in coronary artery disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Galmydar

Snippet

Sponsor: Washington University School of Medicine | Conditions: Coronary Artery Disease | EARLY_Phase 1 | Status: COMPLETED